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Abstract
Background: Ordinary screening of transfusion-transmissible infections (TTIs) among blood donors is essential for
blood transfusion. Although there is several TTIs studies focus on human immunodeficiency virus, hepatitis B and C
viruses, and Treponema pallidum infections in China, it is no data to illustrate any firm conclusion from Shiyan City,
Central China. It aims to verify the seroprevalence of TTIs among blood donors at Shiyan.
Methods: A retrospective analysis of blood donors’ information was conducted for the presence of HIV, HBV, HCV
and T. pallidum. Logistic regression analysis was used to demonstrate risk factors including age, gender and
occupation associated with them. The variation tendency in seroprevalence of these TTIs over the study period was
evaluated by Cochran-Armitage trend test.
Results: Of 211 639 blood donors, 2 858 (1.35 %) had serological evidence of TTIs. The seroprevalence of HIV, HBV, HCV
and T. pallidum were 0.08 %, 0.51 %, 0.20 % and 0.57 %, respectively. However, the co-infection prevalence of TTIs has
not been detected. The HIV seropositivity significantly increased among female donors (OR = 1.63, P < 0.001)
and farmers (OR = 2.02, P = 0.020). Significantly increased HBV seropositivity was only observed framers (OR = 1.87,
P <0.001) compared to workers. Analogously, significantly increased HCV seropositivity was observed among farmers
(OR = 2.59, P < 0.001), students (OR = 2.43, P < 0.001), merchants (OR = 1.70, P = 0.014) and others (OR = 1.78, P =0.001).
The T. pallidum seroprevalence was notably increased among female (OR = 1.54, P < 0.001), and farmers (OR = 1.
70, P <0.001). Moreover, significantly increasing trends of HIV (Z = −6.88, P < 0.01), HBV (Z = −4.52, P < 0.01), HCV
(Z = −4.16, P < 0.01) and T. pallidum (Z = −1.36, P < 0.01) seropositivity were observed over the study period.
Conclusions: It originally offers a substantial prevalence of TTIs among blood donors at Shiyan, Central China.
Severe blood donor selection and all-inclusive screening of blood are highly recommended. It might be helpful
for developing and updating guidance for blood safety.
Trial registration: Retrospectively registered.
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Background
Transfusion-associated infections, mainly human im-
munodeficiency virus (HIV), hepatitis B virus (HBV),
hepatitis C virus (HCV), and Treponema pallidum
among blood donors are serious public health problems.
The World Health Organization (WHO) recommends
conventional and quality-controlled screening of blood
donations for the major TTIs. Over three decades, the
threats of TTIs have been radically dropped via normal
blood testing of blood-borne pathogens [1–3].
While the transfusion-transmissible diseases, which in-
cluding Acquired Immune Deficiency Syndrome (AIDS)
caused by HIV and viral hepatitis infected by HBV, HCV,
proceed to spread particularly in less developed coun-
tries and areas. In 2015, China has harboured 18.84 % of
the world population. Thus, there is no doubt that the
blood supply in China has the potential to influence the
global blood transfusion. Last several decades, all levels
Blood Transfusion Station and Center in China has
strengthened the management of blood examination and
supply. Although the significant achievements has
already obtained during the process, overwhelming
problems remain exists [4]. In China, high prevalence of
TTIs including HIV, HBV, HCV and T. pallidum in the
general populations poses an enormous hazard to blood
safety [5]. Despite a series of studies have surveyed the
TTIs in China [5–8], data revealing the TTIs epidemi-
ology among blood donors is drastically limited. In
addition, accompanied the accelerated social transform-
ation and population mobility, infectious diseases profile
transfers from intestinal infectious diseases to blood-
borne diseases and sexually transmitted diseases (STDs).
In Central China, a car city named Shiyan, which is
also the water source of the Middle Route Project for
South to North Water Transfer, has 3 million popula-
tions including 1 million permanent resident populations
and 2 million floating populations. In partial medical in-
stitutions at different levels (3 of class III comprehensive
hospital, 2 of Tertiary specialized hospital, 15 of the sec-
ondary and the following medical institutions), the blood
consumption was increased from 70 thousand units to
113 thousand units between 2008 and 2010 [9]. Thus,
the blood safety is significant essential and should be
paid enough attention. However, Bloodborne Infectious
Diseases (HIV/AIDS, Hepatitis B & C) and STDs in the
area have not been reported. The main purpose of
current study was to understand the seroprevalence of
pathogens including HIV, HBV, HCV, and T. pallidum
from blood donors between 2010 and 2014 at Shiyan
city, which firstly allowed a sight of increasing incidence
of TTIs in this city of China. The blood safety can be an-
ticipated via monitoring the prevalence of bloodborne
pathogens from blood donations, and then a dependable
indicator for policy formulation can be measured.
Methods
Study design, setting and subjects
A retrospective analysis of data from consecutive, volun-
tary blood donors between January 2010 and December
2014 was carried out at Shiyan Blood Transfusion Center
(SYBTC) and Hubei University of Medicine. Before the
screening, the potential blood donors’ medical history was
checked. Subjects are required to answer questions related
to previous illnesses and medical conditions. History of
blood transfusion and questions interrelated to unsafe sex
are also involved. Healthy individuals (Age 18 to 65 years)
with body weight ≥45 kg would meet the criteria for blood
donation. For healthy blood donors, the medical and
socio-demographic information were recorded and venous
blood were collected in blood banking bags following
Standard Operation Procedures (SOPs).
Ethical statement
All studies were approved by the Ethics Committee of
Shiyan Blood Transfusion Center and Hubei University
of Medicine. Nevertheless, because of the survey and its
limitations (retrospective review of blood donors’ re-
cords), informed consent was not gained from the study
individuals. Then, the gathered information of individ-
uals was anonymized and de-identified prior to analysis.
ABO blood grouping and Rhesus (RH) typing
Determinations of ABO blood groups were carried
out on a microslide using monoclonal blood grouping
antisera: anti-A, anti-B, and anti-AB (Shanghai Hemo-
Pharmaceutical and Biological Co., Ltd., Beijing, China).
Rh blood groups determinations were examined on a
microslide with monoclonal blood grouping anti-D with
Anti-D Blood Grouping Reagent (Millipore UK Ltd.,
Livingston, United Kingdom).
Immunoanalysis of HIV, HBV, HCV and T. pallidum
Serum sample of each blood donor was screened for
HIV using Anti-HIV kit (Beijing Wantai Biological
Pharmacy Enterprise Co., Ltd., Beijing, China) and
HIV Ag/Ab kit (Intec Products Inc., Xiamen, China)
following the manufacturer’s instructions. Serum was
detected for the presence of hepatitis B surface antigen
(HBsAg) using ELISA kits (Beijing Wantai Biological
Pharmacy Enterprise Co., Ltd., Beijing, China; Zhu Hai
Livzon Diagnostics Inc., Zhuhai, China). Similarly, IgG
antibodies of HCV were also detected by ELISA technique
(Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.,
Beijing, China; Zhu Hai Livzon Diagnostics Inc., Zhuhai,
China) according to the instructions of manufacturer.
Serum from all healthy blood donors was detected for the
presence of treponemal antibodies by ELISA kits (Beijing
Wantai Biological Pharmacy Enterprise Co., Ltd., Beijing,
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China; Intec Products Inc., Xiamen, China) following the
manufacturer’s instructions.
Statistical analysis
The data validated and analyzed using Statistical Package
for Social Science (SPSS) for Windows version 17.0
(SPSS Inc., Chicago, IL, USA). The seroprevalences of
HIV, HBV, HCV, and T. pallidum were expressed in
percentages and reported with 95 % confidence inter-
vals (95 % CI) [10] for the entire study group and by
age, gender and geographical region. Differences in
prevalence of TTSs for socio-demographic variables
were checked for significance by logistic regression.
Additionally, the variation tendency in seroprevalence
of these blood-borne pathogens over the study period
was evaluated by Cochran-Armitage trend test from
Statistical Analysis System 9.3 (SAS Institute Inc., NC,
USA). Statistical significance was defined as a P-value
less than 0.05.
Results
Demographic characteristics of blood donors
As shown in Table 1, overall of 212 639 consecutive
blood donors were screened. Of these, 58.1 % blood do-
nors were males and 41.9 % were females. The middle
age of the subjects was 35 years (range 18–65 years). Of
all blood donors, 32.7 % were in the age group of 36–45
years, 32.3 % were blood group O (Table 1). Most do-
nors are resident, but a quote belongs to the floating
population. In addition, workers (18.1 %), students
(10.7 %), farmers (9.0 %), and merchants (8.8 %) consti-
tute a main portion (Table 1).
Trend of HIV, HBV, HCV and T. pallidum seroprevalence
The overall seroprevalence of HIV, HBV, HCV and T.
pallidum were 0.08 % (159/212 639), 0.51 % (1 087/212
639), 0.20 % (414/212 639) and 0.57 % (1 198/212 639),
respectively (Table 2). Considerably increasing trends of
HIV (Z = −6.88, P < 0.01), HBV (Z = −4.52, P < 0.01),
HCV (Z = −4.16, P < 0.01) and T. pallidum (Z = −1.36,
P < 0.01) seroprevalence were observed over the survey
schedule (Fig. 1). The HIV seroprevalence was maintained
at 0.01 % in 2010 and increased to 0.15 % in 2014. The
seroprevalence of HBV was increased from 0.28 % in 2010
to 0.60 % in 2012 but later reduced to 0.49 % in 2013 and
faintly increased to 0.60 % in 2014. Similar to trend of
HBV, HCV prevalence increased steadily from 0.11 % in
2010 to 0.16 % in 2011, 0.27 % in 2012 but subsequently
decreased to 0.17 % in 2013, and increased further to
0.25 % in 2014. On the contrary, the prevalence of T.
pallidum increased progressively from 0.48 % in 2010
to 0.50 % in 2011, 0.68 % in 2012 and then decreased into
0.66 % in 2013 and 0.50 % in 2014 (Fig. 1 and Table 2).
Seroprevalence of HIV, HBV, HCV and T. pallidum
For gender, the seropositivity of HIV (OR = 1.63, P < 0.001)
and T. pallidum (OR = 1.54, P < 0.001) were signifi-
cant difference between male and female, while the
seropositivity of HBV and HCV were no difference
(Table 3 and Table 4).
The seropositivity of HIV in each age group had
roughly the same proportion (Table 3). For vocational
distribution, the seropositivity of HIV were no differ-
ences beyond the farmer (Table 3). The HIV sero-
prevalence was drastically increased among farmers
(OR = 2.02, P = 0.020) compared to workers (Table 3).
The seroprevalence of HBV was significantly increased
among farmers (OR = 1.87, P <0.001) compared to
workers (Table 3). Meanwhile, the seroprevalence of
HBV was decreased among donors from 18 to 25 years
group (OR = 0.72, P < 0.001) and 26–35 years group
(OR = 0.65, P < 0.001) compared to the >45 years group,
among Doctors (OR = 0.46, P <0.001) compared to
workers (Table 3).
Table 1 Socio-demographic characteristics of blood donors
Characteristics No. (%)
Gender
Male 122 951 (58.1)
Female 88 688 (41.9)
Age group (years)
18–25 56 355 (26.6)
26–35 53 751 (25.4)
36–45 69 094 (32.7)
> 45 32439 (15.3)
ABO Blood groups
O Type 68 247 (32.3)
A Type 65 653 (31.0)
B Type 57 843 (27.3)
AB Type 19 896 (9.4)
Occupation
Worker 38 376 (18.1)
Student 22 683 (10.7)
Farmer 19 016 (9.0)
Merchant 18 636 (8.8)
Office staff 14 441 (6.8)
Doctor 13 189 (6.2)
Govt. employee 12 014 (5.7)
Teacher 8 213 (3.9)
Soldier 1 574 (0.8)
Others 63 497 (30.0)
Note: No.=Number. For occupation, the others including housewife,
freelancers and migrant labors
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Among age groups, the seropositivity of HCV were no
difference. For occupation, it was significant differences
for farmers (OR = 2.59, P < 0.001), students (OR = 2.43,
P < 0.001), merchants (OR = 1.70, P = 0.014) and others
(OR = 1.78, P =0.001) compared to workers (Table 4).
The seroprevalence of T. pallidum was significantly in-
creased among farmers (OR = 1.70, P <0.001) compared
to workers (Table 4). Meanwhile, the seroprevalence of T.
pallidum was decreased among donors from 18 to 25
years group (OR = 0.33, P < 0.001) compared to the
>45 years group, among students (OR = 0.24, P <0.001),
doctors (OR = 0.25, P < 0.001), Govt. employee (OR = 0.66,
P = 0.008), Teacher (OR = 0.51, P = 0.001), and Soldier
(OR = 0.32, P = 0.039) compared to workers (Table 4).
Discussion
In study, 211 639 donors had been screened during the
study period. According the socio-demographic charac-
teristics, donors aged 18 to 45 years, workers, students,
farmers, merchants and others including housewife, free-
lancers and migrant labors accounted for the major
component. It notices that although the farmers remain
a relatively small number (9.0 %), the seropositivity of
TTIs is higher than other occupations. The seropreva-
lence of TTIs among female are higher than male. It in-
dicates that the women are under steadily higher
potential threat of TTIs than men. The department of
maternal and child health care should strongly imple-
ment the national women and children development
plan. It should be enhance health promotion program in
community, put more emphasis on the mass screening
and pay more attention to female population in order to
improve their health conditions. For pregnant woman,
the pregnancy testing should be performanced monthly
for the first 28 weeks and then biweekly until 36 weeks,
then weekly until deliver the baby. Besides the regular
checkup, the real-time detection of TTIs should be exe-
cuted base on the medical advice. It was observed signifi-
cantly increasing trends of HIV, HBV, and HCV
seroprevalence were among blood donors over the obser-
vational period. However, none of these blood donors
showed the presence of two or more pathogenic markers.
Of the blood donors, 0.08 % tested positive for HIV. It
is consistent with the previous survey at four Chinese
blood centers from 2000 to 2010 [5]. Furthermore, the
HIV seroprevalence is slightly less than Liaoning, Yan-
cheng and a Rural Area from Shanxi [7], but somewhat
more than Guangzhou and Xian [5, 6]. It is also signifi-
cantly less than African countries such as Ethiopia [11],
Cameroon [12], and Nigeria [13]. However, it is consid-
erably higher than the developed countries including
USA [14], Turkey [15] and Netherlands [16]. For HIV,
the highest infectious burden occurred in the 36–45
years group. More females were seropositive for HIV
than males. College students showed the highest preva-
lence (0.12 %), followed by farmers (0.11 %) and workers
(0.05 %). At present, this phenomenon is a very serious
situation. The occupation distribution and increased
trends of HIV infection observed from the study sug-
gested that a rise in HIV infections in the general popu-
lation could create a protential risk to the blood supply.
Previous survey in China showed that the proportion of
HIV-positive cases related with men who have sex with
men (MSM) have speedily enlarged over the study
period [17]. Although several studies have been done on
HIV infections in Shiyan, no positive patient associated
to MSM was found [17], and this is obviously different
from western countries [18]. We observed an obviously
increasing trend in HIV infection among blood donors
over the study period. It is consistent with the western
countries [18]. It demonstrates that the country is still
faced with a serious situation for AIDS prevention and
Table 2 Seropositivity of HIV, HBV, HCV and Treponema pallidum among blood donors
Year Total screened No. HIV No. (%, 95 % CI) HBV No. (%, 95 % CI) HCV No. (%, 95 % CI) T. pallidum No. (%, 95 % CI)
2010 35 981 5 (0.01, 0–0.02) 101 (0.28, 0.23–0.33) 39 (0.11, 0.08–0.14) 173 (0.48, 0.41–0.55)
2011 40 763 24 (0.06, 0.04–0.08) 232 (0.57, 0.5–0.64) 66 (0.16, 0.12–0.2) 205 (0.50, 0.43–0.57)
2012 41 587 26 (0.06, 0.04–0.08) 249 (0.60, 0.53–0.67) 111 (0.27, 0.22–0.32) 282 (0.68, 0.6–0.76)
2013 45 617 31 (0.07, 0.05–0.09) 222 (0.49, 0.43–0.55) 78 (0.17, 0.13–0.21) 299 (0.66, 0.59–0.73)
2014 47 691 73 (0.15, 0.12–0.18) 283 (0.60, 0.53–0.67) 120 (0.25, 0.21–0.29) 239 (0.50, 0.44–0.56)
Total 211 639 159 (0.08, 0.07–0.09) 1 087 (0.51, 0.48–0.54) 414 (0.20, 0.18–0.22) 1 198 (0.57, 0.54–0.6)
Note: No., N/A, and 95 % CI represent Number, No data, and 95 % confidence interval, respectively
Fig. 1 Trends of seropositivity of HIV, HBV, HCV and Treponema
pallidum among blood donors
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Table 3 Socio–demographic characteristics of blood donors by HIV and HBV seropositivity
Characteristics HIV No. (%, 95 % CI) OR (95 % CI) P-Values HBV No. (%, 95 % CI) OR (95 % CI) P-Values
Gender
Male 73 (0.06, 0.05–0.07) 1.00 N/A 627 (0.51, 0.47–0.55) 1.00 N/A
Female 86 (0.10, 0.08–0.12) 1.63 (1.20–2.23) 0.002 460 (0.52, 0.47–0.57) 1.02 (0.90–1.15) 0.782
Age group (years)
18–25 43 (0.076, 0.05–0.1) 1.08 (0.65–1.79) 0.776 255 (0.45, 0.39–0.51) 0.72 (0.60–0.86) 0.000
26–35 37 (0.069, 0.05–0.09) 0.97 (0.58–1.63) 0.911 221 (0.41, 0.36–0.46) 0.65 (0.54–0.79) 0.000
36–45 56 (0.081, 0.06–0.1) 1.14 (0.70–1.86) 0.589 406 (0.59, 0.53–0.65) 0.93 (0.79–1.10) 0.394
>45 23 (0.071, 0.04–0.1) 1.00 N/A 205 (0.63, 0.54–0.72) 1.00 N/A
Occupation
Worker 21 (0.05, 0.03–0.07) 1.00 N/A 191 (0.50, 0.43–0.57) 1.00 N/A
Student 22 (0.12, 0.07–0.17) 1.77 (0.98–3.23) 0.057 90 (0.40, 0.32–0.48) 0.80 (0.62–1.02) 0.075
Farmer 21 (0.11, 0.06–0.16) 2.02 (1.10–3.70) 0.020 176 (0.93, 0.79–1.07) 1.87 (1.52–2.30) 0.000
Merchant 12 (0.06, 0.02–0.1) 1.18 (0.58–2.39) 0.653 96 (0.52, 0.42–0.62) 1.04 (0.81–1.32) 0.783
Office staff 6 (0.04, 0.01–0.07) 0.76 (0.31–1.88) 0.551 61 (0.42, 0.31–0.53) 0.85 (0.64–1.13) 0.263
Doctor 12 (0.09, 0.04–0.14) 1.66 (0.82–3.38) 0.155 30 (0.23, 0.15–0.31) 0.46 (0.31–0.67) 0.000
Govt. employee 6 (0.05, 0.01–0.09) 0.91 (0.37–2.26) 0.843 52 (0.43, 0.31–0.55) 0.87 (0.64–1.18) 0.370
Teacher 6 (0.07, 0.01–0.13) 1.34 (0.54–3.31) 0.531 38 (0.46, 0.31–0.61) 0.93 (0.66–1.32) 0.680
Soldier 1 (0.06, −0.06-0.18) 1.16 (0.16–8.64) 0.587 4 (0.25, 0–0.5) 0.51 (0.19–1.37) 0.174
Others 52 (0.08, 0.06–0.1) 1.50 (0.90–2.49) 0.116 3497 (0.55, 0.49–0.61) 1.11 (0.93–1.32) 0.269
Note: No., OR, N/A and 95 % CI represent Number, Odd Rate, No data and 95 % confidence interval, respectively
Table 4 Socio–demographic characteristics of blood donors by HCV and Treponema pallidum seropositivity
Characteristics HCV No. (%, 95 % CI) OR (95 % CI) P-Values T. pallidum No. (%, 95 % CI) OR (95 % CI) P-Values
Gender
Male 235 (0.19, 0.17–0.21) 1.00 N/A 569 (0.46, 0.42–0.5) 1.00 N/A
Female 179 (0.20, 0.17–0.23) 1.06 (0.87–1.28) 0.583 629 (0.71, 0.65–0.77) 1.54 (1.37–1.72) 0.000
Age group (years)
18–25 132 (0.23, 0.19–0.27) 1.27 (0.93–1.72) 0.128 132 (0.23, 0.19–0.27) 0.33 (0.27–0.41) 0.000
26–35 96 (0.18, 0.14–0.22) 0.97 (0.70–1.33) 0.831 338 (0.63, 0.56–0.7) 0.89 (0.75–1.05) 0.175
36–45 126 (0.18, 0.15–0.21) 0.99 (0.73–1.34) 0.928 499 (0.72, 0.66–0.78) 1.02 (0.88–1.20) 0.775
>45 60 (0.18, 0.13–0.23) 1.00 N/A 229 (0.71, 0.62–0.8) 1.00 N/A
Occupation
Worker 46 (0.12, 0.09–0.15) 1.00 N/A 228 (0.59, 0.51–0.67) 1.00 N/A
Student 66 (0.29, 0.22–0.36) 2.43 (1.67–3.54) 0.000 32 (0.14, 0.09–0.19) 0.24 (0.16–0.34) 0.000
Farmer 59 (0.31, 0.23–0.39) 2.59 (1.76–3.82) 0.000 191 (1.00, 0.86–1.14) 1.70 (1.40–2.06) 0.000
Merchant 38 (0.20, 0.14–0.26) 1.70 (1.11–2.62) 0.014 136 (0.73, 0.61–0.85) 1.23 (0.99–1.52) 0.056
Office staff 18 (0.12, 0.06–0.18) 1.04 (0.60–1.79) 0.888 79 (0.55, 0.43–0.67) 0.92 (0.71–1.19) 0.526
Doctor 18 (0.14, 0.08–0.2) 1.14 (0.66–1.96) 0.640 20 (0.15, 0.08–0.22) 0.25 (0.16–0.40) 0.000
Govt. employee 20 (0.17, 0.1–0.24) 1.39 (0.82–2.35) 0.218 47 (0.39, 0.28–0.5) 0.66 (0.48–0.90) 0.008
Teacher 13 (0.16, 0.07–0.25) 1.32 (0.71–2.45) 0.374 25 (0.30, 0.18–0.42) 0.51 (0.34–0.77) 0.001
Soldier 1 (0.06, −0.06–0.18) 0.53 (0.07–3.84) 0.792 3 (0.19, −0.03–0.41) 0.32 (0.10–1.0) 0.039
Others 135 (0.21, 0.17–0.25) 1.78 (1.27–2.48) 0.001 437 (0.69, 0.63–0.75) 1.16 (0.99–1.36) 0.071
Note: No., OR, N/A and 95 % CI represent Number, Odd Rate, No data and 95 % confidence interval, respectively
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control. There is no doubt that the health authorities
including all levels of center for disease control
(CDC) and blood stations need to consider strength-
ening efficient and effective measures to prevent this
at-risk population (undergraduate students, farmers
and workers). At present, the CDC could provide the
free HIV consulting, testing and anti-viral treatment.
Thus, the donor could get additional HIV testing way
except the donation. There are implementing some
measures for effective HIV/AIDS prevention and con-
trol. Details are as follows: (1) Actively rejects drugs;
(2) Understanding and caring of AIDS patients; (3)
Offer provider-initiated HIV testing and counselling
(PITC) to all outpatients. Furthermore, some mea-
sures should be done: (1) Avoid unsafe injection or
blood transfusion; (2) Teenagers should take the ini-
tiative to learn the knowledge of AIDS prevention,
and spread knowledge and information to family and
friends. Moreover, it is very necessary to introduce
and develop the technique of nucleic acid testing to
compress the window period of AIDS to enhance and
guarantee clinical blood using security.
In China, the seroprevalence of HBV remains extraor-
dinarily high and approximately 100 million individuals
has the HBV infection [19]. Reports from different
Chinese regions show the HBV seroprevalence ranges
from 0.37 to 3.5 % [5–8]. Total seroprevalence in present
study is lower than Guangzhou [5], Liaoning [5], Xi’an [6],
the Rural Area from Shanxi [7], and western China [8],
but is upper than Yancheng and Nanjing [5]. For the low
HBV prevalence in donors, it might be related to the
Blood donation propaganda and Limitations of detection
methods. For Blood donation propaganda, the potential
blood donation population are not allowed to donate
blood, if they infect with pathogens which include HIV,
HBV, HCV, and others. For detection methods particularly
immunological method, it may underestimates the actual
infection rate for HBV. Thus, the molecular diagnosis in-
cluding polymerase chain reaction (PCR), real time fluor-
escence quantitive Polymerase Chain Reaction (FQ-PCR)
and DNA chip should be introduced and will effectively
ensure the quality of detection. It is noteworthy that the
molecular diagnosis techniques has been widely applied
for blood screening in early 2015 in Shiyan City. Com-
pared with the seroprevalence of HBV infections from de-
veloping countries including Mexico [20], Nepal [21],
South India [22], and some African countries including
Ethiopia [11], Nigeria [23], and Mali [24], HBV harbors
the intermediate level. In view of age distribution, notably
increased in HBV seroprevalence was found in the 36–45
and ≥45 years groups and this is similar to previous re-
ports in Xi’an [6]. However, it is in different from the re-
ports at Northwest Ethiopia, in which higher prevalence
was detected among youths [11]. Data reveals HBV
seroprevalence has a significant rise and remains approxi-
mately steady level since 2011. It is noteworthy that al-
though the HBV remain at the low level, it still need to
strengthen monitoring. For effective control of HBV, spe-
cific measures include (1) Blocking mother-baby transmis-
sion; (2) To avoid iatrogenic transmission and (3) Prevent
horizontal transmission. In China, there is a vaccination
program against HBV and a revaccination schedule that
coverage approximately 8 to 10 million newborns. And
the mandatory schedule will be carried out since postnatal
24 h, 1 month and 6 months. However, the schedule also
include recommended hepatitis b vaccine injection in
people over 15 years old. For occupation, the farmer is the
highest risk group of HBV infection and doctor is the
lowest infectious population. For farmer, the possible
reasons are as follows: (1) Missed diagnosis; (2) Poor
eating habits and (3) Familial infection particularly ver-
tical transmission. For doctor, the possible reasons in-
clude routine physical examination, good eating habits
and reasonable administration. For students, in order
to avoid HBV infection, schools should reinforce the
health education.
In China, a total of 2 %–2.9 % of the population is
HCV patients or infected with HCV [25]. With 18.84 %
of the world population, the estimated HCV-infected
population is more than those in Occident [26]. In
present study, 0.20 % of all blood donors were seroposi-
tive for HCV antibodies. The seroprevalence rate is less
than values ranging between 0.51 % and 12.7 % reported
from other regions of China [5–8, 27]. Of the seroposi-
tive for HCV, 0.19 % was male, while 0.20 % was female.
These results fall in line with historical findings of
Yancheng [5] and Liaoning [5]. However, it is at variance
with the previous reports from Xi’an [6], Nanjing [5] and
Guangzhou [5] in which the anti-HCV positive blood
donors were more widespreaded in male than female.
The HCV infection found in this study is significantly
lower than four Chinese regional blood centers [5], Xi’an
[6] and five Chinese blood stations during 2008–2010
[27]. The 0.38 % found among blood donors in western
part of Turkey [15], the 0.64 % in Nepal [21], the 0.7 %
in Northwest Ethiopia [11], the 6.0 % in Osogbo, south-
west Nigeria [13], and the 11.6 % prevalence reported
among immigrants from Equatorial Guinea Living in
Spain [28]. As a result, the general data in China par-
ticular in Shiyan indicates that the seroprevalence of
HCV infection remains relatively low compared to other
countries around the world [11, 13, 15, 21, 28]. Although
the finding of a low prevalence of anti-HCV antibodies
among apparently healthy blood donors in the study, it
highlights the necessity to continuously monitoring that
will guarantee the safety of blood collection and supply.
For HCV control, there are also some measures should
be abided. Such as strengthen the anti-HCV screening
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and propagation and education, pay attention to per-
sonal hygiene and do check if necessary.
As a one of STDs, syphilis can be diffused via sexual
intercourse/contact, blood transfusion and vertical trans-
mission [11]. In China, the syphilis was eliminated for
two decades (1960–80) following a large scale preven-
tion and control project [6]. However, with the pace of
Chinese economic reform, several STDs including T.
pallidum came back since the 1980s [29, 30]. It reported
incidence rate of T. pallidum in the general population
flew to 0.023 % in 2009 compared with 0.005 % in 1999
[6]. Recently, it has been reported the seroprevalence of
T. pallidum ranged from 0.31 to 0.70 % among blood
donors in different areas of China [5, 6, 8]. The previous
report from India shows the different T. pallidum sero-
prevalence range from 0.19 to 0.28 % [31, 32], the differ-
ence are lower than that in provinces of China. The
study shows the highest seroprevalence of T. pallidum
among the four pathogens. It was observed that 0.57 %
of the prospective blood donors had T. pallidum infection.
In gengeral, the T. pallidum frequently were co-infected
with HIV. However, there is no evidence showed that co-
infection of T. pallidum and HIV in our study. It demon-
strates that the prevalence of T. pallidum is not serious
than other survey in China [33]. The seroprevalence of T.
pallidum (0.57 %) is higher than Nanjing [5], Guangzhou
[5], and Xi’an [6], but is lower than Liaoning and Yan-
cheng [5]. In sub-Saharan Africa, T. pallidum still remains
a severe public health problem. The prevalence of T. palli-
dum infection from African countries showed 1.1 % in
Osogbo, south-west Nigeria [13], 1.2 % in Mozambique
[34], 2.1 % in Burkina Faso, West Africa [35], and 8.1 % in
Douala, Cameroon [12]. Compared with African coun-
tries, the seroprevalence of T. pallidum infection in our
study is significantly low. For the syphilis infection, there
is no obviously increasing or decreasing trend during
2010–2014. It is clearly distinguished with dynamic syph-
ilis infection from western developed countries [36]. How-
ever, none can afford to neglect the T. pallidum infection,
in order to avoid a similar debacle. Thus, there is a very
necessary to screen all blood donors for circulating anti-
bodies to T. pallidum infection, at least as a surrogate
marker. For syphilis prevention of the general population,
some measures are implementing: (1) Tracking patients’
sexual partners and make the necessary treatment; (2)
Checking suspected patients with serological test for syph-
ilis. Furthermore, here are some pointers and tips should
be done: (1) Pregnant women with syphilis should be
given a punctual and effective treatment; (2) Pay attention
to details and avoid to transmit to others. For primary and
secondary school students, the health education is indis-
pensable. Some measures should be carried out: (1) Carry
on the education of standard daily action; (2) Carry on the
education of safe sex; (3) Periodic physical examination.
For occupation, the farmer is the highest risk group of T.
pallidum infection and soldier is the low infectious popu-
lation. Actually, the soldiers have the lower risk compared
with workers. In China, only those whose exam is quali-
fied can be allowed to join the army. Before that, they have
to accept a series of strict examination particular in phys-
ical examination. In army, the soldiers need for absolute
adherence to the management system. All of these condi-
tion guarantee and reduce the rish of infection for the sol-
diers. On the contrary, the residential sanitary condition
and basic medical examination can't guarantee for farmer.
Additionally, this group is lack of awareness of health con-
sciousness, health behavior and ability of self-discipline.
All these resulted in highest risk for farmer.
It's worth noting that there is no co-infections found
in our study. For the absence of co-infections, we de-
duced that due to the low individual prevalence of HIV,
HBV, HCV and syphilis, the co-infections was not likely
to happen. Furthermore, it may be exist the co-
infections but cannot be checked out due to the limita-
tion of immunologic diagnosis. It is also possible that
improvements in technology might have made current
screening reagents more specific and reliable. Thus, we
will improve the detection method in the future study.
In the study, the immunological methods were used to
screen the four pathogens including HIV, HBV, HCV and
T. pallidum. For TTIs, the foremost matter is a “window
period” process, which remains an enduring threats dur-
ing blood transfusion [37, 38]. From the pathogens infec-
tion to the antibody produce, it usually need to be taken
2 weeks to 3 months. During the window period, the
screening of blood donors with pathogens infection will
be negative. This status is commonly happened and makes
the risk for clinical blood consumption. Thus, more sensi-
tivity and specificity screening methods such as nucleic
acid testing including PCR, FQ-PCR, DNA chip and loop-
mediated isothermal amplification (LAMP) [39] should be
adopted to help detecting pathogens earlier and thus di-
minish the risks related with window periods. In 2015, the
blood stations at all levels in Shiyan were recommended
to use nucleic acid test to replace the immunological de-
tection system.
Conclusions
Our study indicates a remarkably low prevalence with rap-
idly increasing trend of TTIs at Shiyan City, Central
China. Transmission of TTIs during the serologically
negative developmental window of opportunity is still suf-
ficient to threaten blood safety. Thus, strict filtering cri-
teria to blood donors with SOPs are highly recommended
to guarantee the blood safety for clinical application. It is
believed that the blood safety will be further guaranteed,
the TTIs and STDs will be effectively prevented in the fu-
ture based on these more sensitive assays in Shiyan city.
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Although the co-infection prevalence of TTIs has not
been found, it still needs to be studied on a large-scale
with molecular detection techniques for the improved un-
derstanding of the influence on clinical application. For ef-
fective prevention and control of TTIs and STDs, it is
very necessary to organize a series of campaigns including
the propaganda of medical policy, vaccination plans, pre-
employment examination, free TTIs testing and so on.
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